Immobilization of free-ranging African wild dogs (Lycaon pictus) using a ketamine/xylazine/atropine combination

被引:0
作者
Osofsky, SA
McNutt, JW
Hirsch, KJ
机构
[1] UNIV CALIF DAVIS,DIV ENVIRONM STUDIES,DAVIS,CA 95616
[2] BOTSWANA DEPT WILDLIFE & NATL PK,GABORONE,BOTSWANA
关键词
wild dog; Lycaon pictus; ketamine hydrochloride; xylazine hydrochloride; yohimbine hydrochloride; pulse oximetry; free-ranging;
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Five free-ranging adult African wild dogs (Lycaon pictus), 24-31 kg, were darted with 35-50 mg ketamine, 60 mg xylazine, and 1.25 mg atropine. Four of five immobilizations had no dart failures, with times to sternal recumbency between 9 and 13 min. Immobilized dogs exhibited complete skeletal muscle relaxation, and none exhibited any signs of arousal during physical examination or sampling. Continuous monitoring of pulse rate and percent oxygen saturation of hemoglobin (Spo(2) trends, in addition to other anesthesia monitoring procedures, indicated no adverse physiologic responses unique to this drug combination. All dogs exhibited relatively stable Spo(2) profiles for the duration of monitoring, with a mean (+/-SD) Spo(2) of 89% +/- 4.9%. Yohimbine administration (2.5 mg i.v., 2.5 mg i.m. or s.c.) 30-37 min after darting provided effective reversal, with times to standing after yohimbine ranging from 2.0 to 10.2 min. All dogs appeared behaviorally normal and returned to their packs after the procedures.
引用
收藏
页码:528 / 532
页数:5
相关论文
共 30 条
[1]  
ALEXANDER KA, 1993, J ZOO WILDLIFE MED, V24, P140
[2]  
CLARK DM, 1982, J AM ANIM HOSP ASSOC, V18, P815
[3]  
EBEDES H, 1979, J S AFR VET ASSOC, V50, P113
[4]  
English R. A., 1993, Koedoe, V36, P103
[5]  
FANSHAWE J H, 1991, Oryx, V25, P137
[6]  
GASCOYNE SC, 1993, J WILDLIFE DIS, V29, P396, DOI 10.7589/0090-3558-29.3.396
[7]  
Gray C.W., 1974, Journal Zool Anim Med, V5, P12, DOI 10.2307/20094264
[8]  
HOLZ P, 1994, J ZOO WILDLIFE MED, V25, P209
[9]  
JACOBSON JD, 1992, AM J VET RES, V53, P537
[10]  
JALANKA HH, 1990, J ZOO WILDLIFE MED, V21, P259